Rankings
▼
Calendar
IOVA Q1 2016 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena
IOVA
Iovance Biotherapeutics, Inc.
$2B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$-0.14
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$101M
Total Liabilities
$2M
Stockholders' Equity
$99M
Cash & Equivalents
$9M
← FY 2016
All Quarters
Q2 2016 →
